Special items: Ovarian Cancer and Us blog best viewed in Firefox

Monday, March 08, 2010

Nektar Reports Positive Phase 2 Clinical Data From First Stage Of NKTR-102 Study In Women With Platinum-Resistant Ovarian Cancer - Quick Facts

Note: warning on stats in article

"The Phase 2 study has now completed enrollment with a total of 71 patients treated. The study is ongoing. Full data are expected to be presented at a major scientific conference in 2010."

No comments:

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.